TGFBR2 and breast carcinoma: BMP7, GDF15, BMP5, SMAD6 and FSTL5 were highly expressed in the ER positive breast cancer cells (MCF-7 cells), while the expressions of TGFBR2, FSTL1 and NOG were reduced in this cohort (Figure 2C).